-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Summit Therapeutics Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2019 to Q2 2024.
- Summit Therapeutics Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$60.4M, a 310% decline year-over-year.
- Summit Therapeutics Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$162M, a 72.9% increase year-over-year.
- Summit Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$615M, a 681% decline from 2022.
- Summit Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$78.8M, a 11.1% increase from 2021.
- Summit Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$88.6M, a 68.1% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)